LL/2（小鼠Lewis肺癌）
CBP60188
詢 價
索取STR
產品描述
產品數據庫
| I. General information | |
| Synonyms: | LL/2(LLC or 3LL) |
| Background: | Lewis lung carcinoma is a cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma. |
| Species: | Mus musculus, mouse |
| Tissue: | lung |
| Disease: | Lewis lung carcinoma |
| Morphology: | rounded - loosely attached or floating |
| Growth Mode: | mixed, adherent and suspension |
| Doubling Time: | 21 hrs |
| Culture Medium: |
DMEM+10%FBS LL/2完全培養基，# CBP60188M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | H-2b |
| Tumor Formation: | Yes, in C57BL mice |
| Comments: | The cells are resistant to 1,3-bis-(2-chloroethyl)-1-nitrosourea, but are sensitive to methotrexate. The cells are reported to be highly tumorigenic, but weakly metastatic in mice. The cells form multilayers in flasks without actually becoming confluent. Tested and found negative for ectromelia virus (mousepox). For more information, please contact us (4008-750-250). |
